Back to Results
First PageMeta Content
Biology / Hepatitis C / Hepatitis C and HIV co-infection / Coinfection / AIDS / Viral load / HIV / Telaprevir / Antiretroviral drug / HIV/AIDS / Health / Medicine


HepCVer5.qxd[removed]:58 AM
Add to Reading List

Document Date: 2007-04-11 13:16:54

Open Document

File Size: 593,46 KB

Share Result on Facebook

Company

Alteon Inc. / /

Continent

Africa / /

Country

United States / /

/

Event

FDA Phase / /

Facility

NYU Medical Center / /

/

IndustryTerm

treatment of hepatitis C / HCV Therapy / AIDS Treatment / HIV Therapy / treating for HIV / treatment of HCV / Web Site www.natap.org / HCV Treatment / Treatment for HCV / Hepatitis Treatment / Therapy for HCV / /

MedicalCondition

hepatitis A / liver inflammation / HIV / Liver Failure / HCV-related liver fibrosis / nausea / Cirrhosis / herpes / Hepatitis C / hepatitis B / chronic mana geable disease / HCV-related liver failure / fatigue / mild fatigue / end stage liver disease / Hepatitis / HCV infections / liver disease / hepatitis C. It / insulin resistance / Disease / HCV liver disease / faster and more serious liver disease / hepatocelluar carcinoma / sickness / HCV / itching / Person Get Hepatitis C / Liver Cancer / STDs / both infections / infection / Fatty Liver / chronic infection / advanced liver disease / inflammation / Statistics About Hepatitis C / HCV disease / chronic hepatitis C / Fibrosis / /

MedicalTreatment

HAART / /

Organization

NYU Medical Center / /

Person

Jules Levin / NATAP NATAP / /

/

Position

Executive Director / /

Product

IV / ribavirin / HCV / /

Technology

genotype / /

URL

www.natap.org / http /

SocialTag